In TME, the higher frequency of IFN-γ+CD8+CD226+TILs was correlated with up-regulated TIGIT expression, which could serve as an essential and potential biomarker to predict the progress and immune evasion in GC patients. The gene discussed is CD226; the disease is gastric cancer.